微信公众号

官网二维码

中国癌症防治杂志 ›› 2021, Vol. 13 ›› Issue (2): 155-163.doi: 10.3969/j.issn.1674-5671.2021.02.08

• 癌情监测 • 上一篇    下一篇

2016年山西省肿瘤登记地区肝癌发病与死亡分析

  

  1. 山西省肿瘤医院流行病室
  • 出版日期:2021-04-25 发布日期:2021-04-30
  • 通讯作者: 张永贞 E-mail:zyzzhang2003@163.com

Analysis of incidence and mortality of liver cancer in Shanxi cancer  registries,2016

  • Online:2021-04-25 Published:2021-04-30

摘要: 目的 分析2016年山西省肿瘤登记地区居民肝癌发病、死亡情况,为制订肝癌防治策略提供依据。方法 收集山西省12个肿瘤登记地区居民肝癌发病和死亡资料,统计肝癌发病率、死亡率等指标,分别采用2000年中国标准人口年龄构成和Segi's世界标准人口年龄构成计算中标率和世标率,分析不同性别、年龄、以及城乡居民肝癌发病率和死亡率。结果 2016年山西省肿瘤登记地区肝癌新发病例754例,发病率为15.42/10万(男性19.40/10万,女性11.29/10万),中标率和世标率分别为10.72/10万、10.75/10万;城市地区发病率为10.14/10万,中标率为6.73/10万;农村地区发病率为19.00/10万,中标率为13.48/10万。山西省肿瘤登记地区肝癌死亡病例761例,死亡率为15.56/10万(男性19.80/10万,女性11.17/10万),中标率和世标率分别为10.71/10万、10.86/10万。城市地区死亡率14.90/10万,中标率为9.86/10万,农村地区死亡率为16.01/10万,中标率为11.37/10万。肝癌发病率和死亡率均随年龄增加呈上升趋势,35岁以后发病率上升较为明显,全省发病率和死亡率分别在80岁和85岁年龄组达到高峰,男性高于女性。结论 山西省肿瘤登记地区肝癌发病率和死亡率均低于全国平均水平,男性发病率高于女性,农村地区发病率高于城市地区,应将男性及农村地区人群作为肝癌防治的重点对象。

关键词: 肝癌, 发病率, 死亡率, 肿瘤登记, 山西

Abstract: Objective To analyze the incidence and mortality of liver cancer in Shanxi cancer registries in 2016, and to provide the strategies of prevention and treatment of liver cancer. Methods The incidence and mortality data of liver cancer in 12 cancer registries of Shanxi Province were collected with recording the incidence, mortality. The age-standardized of Chinese standard population (ASR China) and world standard population (ASR world) were calculated by the Chinese standard population in 2000 and Segi's population, respectively. The incidence and mortality rates of liver cancer were analyzed based on the stratification of the gender , age and areas (urban and rural). Results In 2016, 754 new cases of liver cancer were recorded in Shanxi cancer registries, with the incidence of 15.42/105 (male: 19.40/105, female: 11.29/105), ASR China of 10.72/105 and the ASR world of 10.75/105. The incidence in urban areas was 10.14/105, and ASR China was 6.73/105; the incidence in rural areas was 19.00/105, and ASR China was 13.48/105. A total of 761 cases died of liver cancer in Shanxi cancer registries, with the mortality rate of 15.56/105 (male: 19.80/105, female: 11.17/105), ASR China of 10.71/105 and the ASR world of 10.86/105. The mortality rate of urban areas was 14.90/105, and ASR China was 9.86/105; the mortality rate of rural areas was 16.01/105, and ASR China was 11.37/105. The incidence and mortality of liver cancer both increased with age, and the incidence increased more significantly after the age of 35. The incidence and mortality in Shanxi Province reached the peak in the age group of 80 years and 85 years, respectively, and the male was higher than the female. Conclusions The incidence and mortality rates of liver cancer in Shanxi cancer registries are lower than the national average, the male is higher than the female, and higher in rural areas than in urban areas. Therefore, the prevention and treatment of liver cancer should focus on males and people in rural areas.

Key words: Liver cancer, Incidence, Mortality, Cancer registries, Shanxi

中图分类号: 

  • R735.7